TY - JOUR
T1 - Isolation of two novel genes, DSCR5 and DSCR6, from Down syndrome critical region on human chromosome 21q22.2
AU - Shibuya, Kazunori
AU - Kudoh, Jun
AU - Minoshima, Shinsei
AU - Kawasaki, Kazuhiko
AU - Asakawa, Shuichi
AU - Shimizu, Nobuyoshi
N1 - Funding Information:
The authors thank Miss Mio Takahashi for technical assistance and all the members of genomic sequencing team in the Laboratory of Genomic Medicine for their contribution to this work. This work was supported in part by Fund for Human Genome Sequencing Project from the Japan Science and Technology Corporation (JST); Grant in Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan; and Grant in Aid for Scientific Research and Fund for “Research for the Future” Program from the Japan Society for the Promotion of Science (JSPS).
PY - 2000/5/19
Y1 - 2000/5/19
N2 - We have isolated two novel genes, designated DSCR5 and DSCR6, from the Down syndrome critical region (DSCR) on chromosome 21q22.2 which has been defined as minimal overlapping region of partial trisomy 21 patients and located between t(4;21) break point and ERG (approximately 1.6 Mb). DSCR5 and DSCR6 genes consist of 6 and 5 exons, respectively. Alternative use of transcription start sites and alternative splicing events produce different RNA species and proteins from both genes. Three different transcripts of DSCR5 gene encode three putative trans-membrane proteins of 158, 134, and 108 amino acids, while 4 different transcripts of DSCR6 gene encode two forms of proteins with 190 and 106 amino acids. The DSCR5 gene is expressed in various human tissues examined, whereas the DSCR6 gene is expressed only in limited tissues at low level. Both DSCR5 and DSCR6 genes are candidates for the pathogenesis of Down syndrome, although the function of these genes remains to be elucidated. (C) 2000 Academic Press.
AB - We have isolated two novel genes, designated DSCR5 and DSCR6, from the Down syndrome critical region (DSCR) on chromosome 21q22.2 which has been defined as minimal overlapping region of partial trisomy 21 patients and located between t(4;21) break point and ERG (approximately 1.6 Mb). DSCR5 and DSCR6 genes consist of 6 and 5 exons, respectively. Alternative use of transcription start sites and alternative splicing events produce different RNA species and proteins from both genes. Three different transcripts of DSCR5 gene encode three putative trans-membrane proteins of 158, 134, and 108 amino acids, while 4 different transcripts of DSCR6 gene encode two forms of proteins with 190 and 106 amino acids. The DSCR5 gene is expressed in various human tissues examined, whereas the DSCR6 gene is expressed only in limited tissues at low level. Both DSCR5 and DSCR6 genes are candidates for the pathogenesis of Down syndrome, although the function of these genes remains to be elucidated. (C) 2000 Academic Press.
UR - http://www.scopus.com/inward/record.url?scp=0034685632&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034685632&partnerID=8YFLogxK
U2 - 10.1006/bbrc.2000.2685
DO - 10.1006/bbrc.2000.2685
M3 - Article
C2 - 10814524
AN - SCOPUS:0034685632
SN - 0006-291X
VL - 271
SP - 693
EP - 698
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -